Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818)
FRANKFURT:818
818 Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
818 Stock 12 Month Forecast
Average Price Target
€3.34
▲(44.08% Upside)
| Highest Price Target€3.54 | Average Price Target€3.34 | Lowest Price Target€3.21 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Unknown Analyst
SPDBNot Ranked
SPDB
€3.32
Buy
43.12%
Upside
Reiterated
08/20/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Unknown Analyst
SPDBNot Ranked
SPDB
€3.32
Buy
43.12%
Upside
Reiterated
08/20/25
Best Analysts Covering Zylox-Tonbridge Medical Technology Co., Ltd. Class H
3 Months
xxx
Success Rate
3/3 ratings generated profit
Average Return
+10.03%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.03% per trade.
1 Year
Success Rate
1/2 ratings generated profit
Average Return
-0.75%
reiterated a buy rating 3 months ago
Copying PerPlexity Health Care EU's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -0.75% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
Average Return
-0.75%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
818 Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Mar 26
Strong Buy
11
8
8
3
5
Buy
0
0
0
0
0
Hold
15
15
15
5
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
23
23
8
10
Each month's total comprises the sum of three months' worth of ratings.
818 Financial Forecast
818 Stock Forecast FAQ
What is DE:818’s average 12-month price target, according to analysts?
Based on analyst ratings, Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s 12-month average price target is 3.34.
What is DE:818’s upside potential, based on the analysts’ average price target?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has 44.08% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Zylox-Tonbridge Medical Technology Co., Ltd. Class H a Buy, Sell or Hold?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s share price target?
The average share price target for Zylox-Tonbridge Medical Technology Co., Ltd. Class H is 3.34. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €3.54 ,and the lowest forecast is €3.21. The average share price target represents 44.08% Increase from the current price of €2.32.
The highest analyst share price target is €3.54 ,and the lowest forecast is €3.21. The average share price target represents 44.08% Increase from the current price of €2.32.
What do analysts say about Zylox-Tonbridge Medical Technology Co., Ltd. Class H?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Zylox-Tonbridge Medical Technology Co., Ltd. Class H?
To buy shares of DE:818, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.